位置:首页 > 蛋白库 > RL3L_HUMAN
RL3L_HUMAN
ID   RL3L_HUMAN              Reviewed;         407 AA.
AC   Q92901;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=60S ribosomal protein L3-like;
DE   AltName: Full=Large ribosomal subunit protein uL3-like;
GN   Name=RPL3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart muscle;
RX   PubMed=8921388; DOI=10.1006/geno.1996.0538;
RA   van Raay T.J., Connors T.D., Klinger K.W., Landes G.M., Burn T.C.;
RT   "A novel ribosomal protein L3-like gene (RPL3L) maps to the autosomal
RT   dominant polycystic kidney disease gene region.";
RL   Genomics 37:172-176(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11157797; DOI=10.1093/hmg/10.4.339;
RA   Daniels R.J., Peden J.F., Lloyd C., Horsley S.W., Clark K., Tufarelli C.,
RA   Kearney L., Buckle V.J., Doggett N.A., Flint J., Higgs D.R.;
RT   "Sequence, structure and pathology of the fully annotated terminal 2 Mb of
RT   the short arm of human chromosome 16.";
RL   Hum. Mol. Genet. 10:339-352(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANT CMD2D HIS-116, AND INVOLVEMENT IN CMD2D.
RX   PubMed=32870709; DOI=10.1161/circgen.120.002969;
RA   Al-Hassnan Z.N., Almesned A., Tulbah S., Alakhfash A., Alhadeq F.,
RA   Alruwaili N., Alkorashy M., Alhashem A., Alrashdan A., Faqeih E.,
RA   Alkhalifi S.M., Al Humaidi Z., Sogaty S., Azhari N., Bakhaider A.M.,
RA   Al Asmari A., Awaji A., Albash B., Alhabdan M., Alghamdi M.A.,
RA   Alshuaibi W., Al-Hassnan R.Z., Alshenqiti A., Alqahtani A., Shinwari Z.,
RA   Rbabeh M., Takroni S., Alomrani A., Albert Brotons D.C., Alqwaee A.M.,
RA   Almanea W., Alfadley F.A., Alfayyadh M., Alwadai A.;
RT   "Categorized genetic analysis in childhood-onset cardiomyopathy.";
RL   Circ. Genom. Precis. Med. 13:504-514(2020).
RN   [5]
RP   VARIANTS CMD2D ASP-27; TRP-161; MET-189; ASN-308; VAL-308 AND TRP-343, AND
RP   INVOLVEMENT IN CMD2D.
RX   PubMed=32514796; DOI=10.1007/s00439-020-02188-6;
RA   Ganapathi M., Argyriou L., Martinez-Azorin F., Morlot S., Yigit G.,
RA   Lee T.M., Auber B., von Gise A., Petrey D.S., Thiele H., Cyganek L.,
RA   Sabater-Molina M., Ahimaz P., Cabezas-Herrera J., Sorli-Garcia M.,
RA   Zibat A., Siegelin M.D., Burfeind P., Buchovecky C.M., Hasenfuss G.,
RA   Honig B., Li Y., Iglesias A.D., Wollnik B.;
RT   "Bi-allelic missense disease-causing variants in RPL3L associate neonatal
RT   dilated cardiomyopathy with muscle-specific ribosome biogenesis.";
RL   Hum. Genet. 139:1443-1454(2020).
CC   -!- DISEASE: Cardiomyopathy, dilated 2D (CMD2D) [MIM:619371]: A form of
CC       dilated cardiomyopathy, a disorder characterized by ventricular
CC       dilation and impaired systolic function, resulting in congestive heart
CC       failure and arrhythmia. Patients are at risk of premature death. CMD2D
CC       is an autosomal recessive, severe form with neonatal onset.
CC       {ECO:0000269|PubMed:32514796, ECO:0000269|PubMed:32870709}. Note=The
CC       disease may be caused by variants affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the universal ribosomal protein uL3 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U65581; AAC50777.1; -; mRNA.
DR   EMBL; AE006640; AAK61301.1; -; Genomic_DNA.
DR   EMBL; BC050413; AAH50413.1; -; mRNA.
DR   CCDS; CCDS10450.1; -.
DR   RefSeq; NP_005052.1; NM_005061.2.
DR   AlphaFoldDB; Q92901; -.
DR   SMR; Q92901; -.
DR   BioGRID; 112043; 65.
DR   IntAct; Q92901; 6.
DR   STRING; 9606.ENSP00000268661; -.
DR   iPTMnet; Q92901; -.
DR   PhosphoSitePlus; Q92901; -.
DR   SwissPalm; Q92901; -.
DR   BioMuta; RPL3L; -.
DR   DMDM; 2500230; -.
DR   EPD; Q92901; -.
DR   jPOST; Q92901; -.
DR   MassIVE; Q92901; -.
DR   MaxQB; Q92901; -.
DR   PaxDb; Q92901; -.
DR   PeptideAtlas; Q92901; -.
DR   PRIDE; Q92901; -.
DR   ProteomicsDB; 75583; -.
DR   Antibodypedia; 23334; 69 antibodies from 22 providers.
DR   DNASU; 6123; -.
DR   Ensembl; ENST00000268661.8; ENSP00000268661.7; ENSG00000140986.8.
DR   GeneID; 6123; -.
DR   KEGG; hsa:6123; -.
DR   MANE-Select; ENST00000268661.8; ENSP00000268661.7; NM_005061.3; NP_005052.1.
DR   UCSC; uc002cnh.4; human.
DR   CTD; 6123; -.
DR   DisGeNET; 6123; -.
DR   GeneCards; RPL3L; -.
DR   HGNC; HGNC:10351; RPL3L.
DR   HPA; ENSG00000140986; Group enriched (skeletal muscle, tongue).
DR   MIM; 617416; gene.
DR   MIM; 619371; phenotype.
DR   neXtProt; NX_Q92901; -.
DR   OpenTargets; ENSG00000140986; -.
DR   PharmGKB; PA34746; -.
DR   VEuPathDB; HostDB:ENSG00000140986; -.
DR   eggNOG; KOG0746; Eukaryota.
DR   GeneTree; ENSGT00390000017606; -.
DR   HOGENOM; CLU_033361_1_0_1; -.
DR   InParanoid; Q92901; -.
DR   OMA; QMKKYCS; -.
DR   OrthoDB; 793191at2759; -.
DR   PhylomeDB; Q92901; -.
DR   TreeFam; TF300555; -.
DR   PathwayCommons; Q92901; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SignaLink; Q92901; -.
DR   SIGNOR; Q92901; -.
DR   BioGRID-ORCS; 6123; 12 hits in 1074 CRISPR screens.
DR   GenomeRNAi; 6123; -.
DR   Pharos; Q92901; Tbio.
DR   PRO; PR:Q92901; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q92901; protein.
DR   Bgee; ENSG00000140986; Expressed in skeletal muscle tissue of rectus abdominis and 103 other tissues.
DR   ExpressionAtlas; Q92901; baseline and differential.
DR   Genevisible; Q92901; HS.
DR   GO; GO:0022625; C:cytosolic large ribosomal subunit; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005840; C:ribosome; TAS:ProtInc.
DR   GO; GO:0003723; F:RNA binding; IBA:GO_Central.
DR   GO; GO:0003735; F:structural constituent of ribosome; IBA:GO_Central.
DR   GO; GO:0006412; P:translation; IBA:GO_Central.
DR   Gene3D; 4.10.960.10; -; 1.
DR   InterPro; IPR045077; L3_arc_euk.
DR   InterPro; IPR000597; Ribosomal_L3.
DR   InterPro; IPR019926; Ribosomal_L3_CS.
DR   InterPro; IPR044892; Ribosomal_L3_dom_3_arc_sf.
DR   InterPro; IPR009000; Transl_B-barrel_sf.
DR   PANTHER; PTHR11363; PTHR11363; 1.
DR   Pfam; PF00297; Ribosomal_L3; 1.
DR   SUPFAM; SSF50447; SSF50447; 1.
DR   PROSITE; PS00474; RIBOSOMAL_L3; 1.
PE   1: Evidence at protein level;
KW   Cardiomyopathy; Disease variant; Reference proteome; Ribonucleoprotein;
KW   Ribosomal protein.
FT   CHAIN           1..407
FT                   /note="60S ribosomal protein L3-like"
FT                   /id="PRO_0000077233"
FT   REGION          1..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          387..407
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..28
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        388..407
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VARIANT         27
FT                   /note="G -> D (in CMD2D; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32514796"
FT                   /id="VAR_085880"
FT   VARIANT         116
FT                   /note="R -> H (in CMD2D; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32870709"
FT                   /id="VAR_085881"
FT   VARIANT         161
FT                   /note="R -> W (in CMD2D; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32514796"
FT                   /id="VAR_085882"
FT   VARIANT         189
FT                   /note="T -> M (in CMD2D; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32514796"
FT                   /id="VAR_085883"
FT   VARIANT         291
FT                   /note="P -> L (in dbSNP:rs34265469)"
FT                   /id="VAR_034461"
FT   VARIANT         308
FT                   /note="D -> N (in CMD2D; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32514796"
FT                   /id="VAR_085884"
FT   VARIANT         308
FT                   /note="D -> V (in CMD2D; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32514796"
FT                   /id="VAR_085885"
FT   VARIANT         343
FT                   /note="R -> W (in CMD2D; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32514796"
FT                   /id="VAR_085886"
SQ   SEQUENCE   407 AA;  46296 MW;  1965327E225F80D2 CRC64;
     MSHRKFSAPR HGHLGFLPHK RSHRHRGKVK TWPRDDPSQP VHLTAFLGYK AGMTHTLREV
     HRPGLKISKR EEVEAVTIVE TPPLVVVGVV GYVATPRGLR SFKTIFAEHL SDECRRRFYK
     DWHKSKKKAF TKACKRWRDT DGKKQLQKDF AAMKKYCKVI RVIVHTQMKL LPFRQKKAHI
     MEIQLNGGTV AEKVAWAQAR LEKQVPVHSV FSQSEVIDVI AVTKGRGVKG VTSRWHTKKL
     PRKTHKGLRK VACIGAWHPA RVGCSIARAG QKGYHHRTEL NKKIFRIGRG PHMEDGKLVK
     NNASTSYDVT AKSITPLGGF PHYGEVNNDF VMLKGCIAGT KKRVITLRKS LLVHHSRQAV
     ENIELKFIDT TSKFGHGRFQ TAQEKRAFMG PQKKHLEKET PETSGDL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024